Agency for Healthcare Research and Quality (AHRQ). (2020, January 2). Treatments for Acute Pain: A Systematic Review. Retrieved March 5, 2021 from https://effectivehealthcare.ahrq.gov/products/treatments-acute-pain/protocol.
Agency for Healthcare Research and Quality (AHRQ). (2019). Opioid Treatments for Chronic Pain. Retrieved December 20, 2020 from https://effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/protocol.
American Society of Addiction Medicine (ASAM). (2019). Definition of Addiction. Retrieved March 4, 2020 from https://www.asam.org/Quality-Science/definition-of-addiction.
American Society of Addiction Medicine (ASAM). (2015). National Practice Guideline in the Use of Medications for the Treatment of Addiction Involving Opioid Use. Retrieved January 15, 2021 from https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf.
Baker DW. (2017). The Joint Commission’s Pain Standards: Origins and Evolution. Retrieved May 3, 2021 from https://www.jointcommission.org/-/media/tjc/documents/resources/pain-management/pain_std_history_web_version_05122017pdf.pdf?db=web&hash=E7D12A5C3BE9DF031F3D8FE0D8509580.
Bernard SA, Chelminski PR, Ives TJ, et al. (2018). Management of pain in the United States: A brief history and implications for the opioid epidemic. Health Services Insights. Retrieved February 1, 2021 from https://journals.sagepub.com/doi/full/10.1177/1178632918819440.
Burke MA, Sullivan R. (2020). Medication-assisted Treatment for Opioid Use Disorder in Rhode Island: Who Gets Treatment, and Does Treatment Improve Health Outcomes? New England Public Policy Center Research Report 20-3. Retrieved April 26, 2021 from file:///C:/Users/laure/Downloads/neppcrr2003.pdf.
Carter JA, Black LK, Sharma D, et al. (2020). Efficacy of non-opioid analgesics to control postoperative pain: A network meta-analysis. BMC Anesthesiol 20, 272. Doi:10.1186/s12871-020-01147-y. Retrieved January 19, 2021 from https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-020-01147-y.
Centers for Disease Control and Prevention (CDC). (2021, January 26). Opioid Overdose: Commonly Used Terms. Retrieved March 4, 2021 from https://www.cdc.gov/drugoverdose/opioids/terms.html.
Centers for Disease Control and Prevention (CDC). (2021, January 25). Opioid Data Analysis and Resources. Retrieved March 3, 2021 from https://www.cdc.gov/drugoverdose/data/analysis.html.
Centers for Disease Control and Prevention (CDC). (2020, December 17). Overdose Deaths Accelerating During COVID-19. Expanded Prevention Efforts Needed. Retrieved January 29, 2021 from https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html.
Centers for Disease Control and Prevention (CDC). (2020, September 4). Overdose Deaths and the Involvement of Illicit Drugs. Vital Signs. Retrieved February 8, 2021 from https://www.cdc.gov/drugoverdose/pubs/featured-topics/VS-overdose-deaths-illicit-drugs.html.
Centers for Disease Control and Prevention (CDC). (2020, September 3). Overdose Graphics. Retrieved February 8, 2021 from https://www.cdc.gov/drugoverdose/resources/overdose-graphics.html.
Centers for Disease Control and Prevention (CDC). (2017, July 6). Opioid Prescribing: Where you live matters. Vital Signs. Retrieved March 3, 2021 from https://www.cdc.gov/vitalsigns/opioids/index.html.
Chibi B, Torres NF, Mashamba-Thompson TP. (2020). Prescription drug diversion, misuse, and abuse among people living with HIV: A scoping review protocol. Syst Rev 9, 29. Doi:10.1186/s13643-020-1273-4. Retrieved December 22, 2020 from https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-1273-4.
Desmon S. (2020). A Crisis Within a Crisis. Hub. Johns Hopkins University. Retrieved January 19, 2021 from https://hub.jhu.edu/2020/12/14/opioid-crisis-coronavirus-pandemic-purdue-pharma-settlement/.
Dixon DW. (2018). Opioid Abuse: Practice Essentials, Background, Pathophysiology. Retrieved December 22, 2020 from https://emedicine.medscape.com/article/287790-overview#showall.
Fan M, Tscheng D, Hamilton M, et al. (2019). Diversion of controlled drugs in hospitals: A scoping review of contributors and safeguards. J. Hosp. Med 7;419–28. Doi:10.12788/jhm.3228. Retrieved December 23, 2020 from https://www.journalofhospitalmedicine.com/jhospmed/article/202732/hospital-medicine/diversion-controlled-drugs-hospitals-scoping-review#jhm1406-sec-0003.
Federation of State Medical Boards (FSMB). (2017). Guidelines for the Chronic Use of Opioid Analgesics. Retrieved December 22, 2020 from https://www.fsmb.org/siteassets/advocacy/policies/opioid_guidelines_as_adopted_april-2017_final.pdf.
Feinberg T, Jones DL, Lilly C, et al. (2018). The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain. PLOS One. Retrieved January 18, 2021 from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196390.
Food and Drug Administration (FDA). (2019). News release. FDA approves first generic naloxone nasal spray to treat opioid overdose. Retrieved March 6, 2021 from https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-naloxone-nasal-spray-treat-opioid-overdose.
Heyward J, Jones CM, Compton WM, et al. (2018). JAMA Netw Open 1(6):e183044. Doi:10.1001/jamanetworkopen.2018.3044. Retrieved January 19, 2021 from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2705853.
International Association for the Study of Pain (IASP). (2018). IASP Statement on Opioids. Retrieved December 20, 2020 from http://www.iasp-pain.org/Advocacy/Content.aspx?ItemNumber=7194.
Joint Commission, The. (2019). Drug diversion and impaired health care workers. Quick Safety; Issue 48; April 2019. Retrieved January 26, 2021 from https://www.jointcommission.org/-/media/tjc/newsletters/quick_safety_drug_diversion_final2pdf.pdf.
Joint Commission, The. (2017). Pain Assessment and Management Standards for Hospitals. Retrieved March 5, 2021 from https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_report_issue_11_2_11_19_rev.pdf.
Lake S, Walsh Z, Kerr T, et al. (2019). Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLOS Medicine. Retrieved January 19, 2021 from https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002967.
Lopez G. (2018, May 15). The growing number of lawsuits against opioid companies, explained. Retrieved December 22, 2020 from https://www.vox.com/policy-and-politics/2017/6/7/15724054/opioid-epidemic-lawsuits-purdue-oxycontin.
Martin J, Cunliffe J, Décary-Hétu D, Aldridge J. (2018). Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: Interrupted time series analysis. BMJ 361:k2270. Retrieved December 22, 2020 from https://www.bmj.com/content/361/bmj.k2270.
National Center for Complementary and Integrative Health. (NCCIH). (2021). Chronic Pain: In Depth. Retrieved January 15, 2021 from https://www.nccih.nih.gov/health/chronic-pain-in-depth.
National Center for Complementary and Integrative Health (NCCIH). (2020). Chronic Pain: In Depth. NCCIH Pub No. D456. Retrieved December 15, 2020 from https://nccih.nih.gov/health/pain/chronic.htm.
National Center for Health Statistics (NCHS). (2021). Provisional Drug Overdose Death Counts. Retrieved February 16, 2021 from https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
National Harm Reduction Coalition (NHRC). (2021). Principles of Harm Reduction. Retrieved May 24, 2021 from https://harmreduction.org/about-us/principles-of-harm-reduction/.
National Institute on Drug Abuse (NIDA). (2020, June). Misuse of Prescription Drugs Research Report Overview. Retrieved February 8, 2021 from https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/overview–20
National Institute on Drug Abuse (NIDA). (2019, January). Treatment Approaches for Drug Addiction. Retrieved May 3, 2021 from https://www.drugabuse.gov/sites/default/files/drugfacts-treatmentapproaches.pdf.
National Institute on Drug Abuse (NIDA). (2018, June). Medications to Treat Opioid Use Disorder Research Report: How do medications to treat opioid use disorder work? Retrieved March 6, 2021 from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/how-do-medications-to-treat-opioid-addiction-work.
National Institute on Drug Abuse (NIDA). (2018, January). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institutes of Health; U.S. Department of Health and Human Services. Retrieved May 2, 2021 from https://www.drugabuse.gov/download/675/principles-drug-addiction-treatment-research-based-guide-third-edition.pdf?v=74dad603627bab89b93193918330c223.
National Institute on Drug Abuse (NIDA). (2017). Improving Opioid Prescribing. Opioid Prescribers Can Play a Key Role in Stopping the Opioid Overdose Epidemic. Retrieved March 5, 2021 from https://www.drugabuse.gov/publications/improving-opioid-prescribing.
National Library of Medicine (NLM). (2021). Compound Summary: Lofexidine. Retrieved April 25, 2021 from https://pubchem.ncbi.nlm.nih.gov/compound/Lofexidine#section=NORMAN-Suspect-List-Exchange-Classification.
Oviedo-Joekes E, MacDonald S, Boissonneault C. et al. (2021). Take home injectable opioids for opioid use disorder during and after the COVID-19 pandemic is in urgent need: A case study. Subst Abuse Treat Prev Policy 16, 22. Doi:10.1186/s13011-021-00358-x. Retrieved April 26, 2021 from https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-021-00358-x.
Prevent Overdose RI. (2020a). Overdose Death Data. Retrieved March 7, 2021 from https://preventoverdoseri.org/overdose-deaths/.
Prevent Overdose RI. (2020b). Get Naloxone. Retrieved March 7, 2021 from https://preventoverdoseri.org/get-naloxone/.
Rhode Island Department of Health (RIDOH). (2018). Frequently Asked Questions About July 2018 Updated Pain Management Regulations. Retrieved February 16, 2021 from https://health.ri.gov/publications/frequentlyaskedquestions/PainMgmtRegs.pdf.
Schneberk T, Raffetto B, Friedman J, et al. (2020). Opioid prescription patterns among patients who doctor shop: Implications for providers. PLoS ONE 15(5): e0232533. Doi:10.1371/journal.pone.0232533. Retrieved December 23, 2020 from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232533.
Schuckit M. (2016). Treatment of Opioid Use Disorders. NEJM 375(4):357. Retrieved March 6, 2021 from http://www.nejm.org/doi/full/10.1056/NEJMra1604339#t=article.
Spithoff S, Leece P, Sullivan F et al. (2020). Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing. PLoS ONE 15(1): e0227045. Doi:10.1371/journal.pone.0227045. Retrieved January 9, 2021 from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227045#sec005.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2021). Medication-Assisted Treatment (MAT). Retrieved May 4, 2021 from https://www.samhsa.gov/medication-assisted-treatment.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2020, September 11). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Retrieved December 14, 2020 from https://www.samhsa.gov/data/report/2019-nsduh-annual-national-report.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2020, May). TIP 63: Medications for Opioid Use Disorder. Retrieved February 8, 2021 from https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP20-02-01-006.
Tsai AC, Kiang MV, Barnett ML, et al. (2019). Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med 16(11): e1002969. Doi:10.1371/journal.pmed.1002969. Retrieved March 5, 2021 from https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002969.
U.S Department of Health and Human Services (HHS). (2018). Facing Addiction in America: The Surgeon General’s Spotlight on Opioids. Office of the Surgeon General. Retrieved January 16, 2021 from https://addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-Opioids_09192018.pdf.
Volkow ND. (2020). Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine. Doi:10.7326/M20-1212. Retrieved February 8, 2021 from https://www.acpjournals.org/doi/10.7326/m20-1212.
Yang JC, Roman-Urrestarazu A, Brayne C. (2020). Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007–2016. PLoS ONE 15(3). Doi:10.1371/journal.pone.0229787. Retrieved March 4, 2021 from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229787.
Zimmerman B. (2017, February 28). Becker’s Hospital Review. 7 Things to Know About the History of The Joint Commission Pain Standards. Retrieved December 20, 2020 from https://www.beckershospitalreview.com/opioids/7-things-to-know-about-the-history-of-the-joint-commission-pain-standards.html.